NCEL Form 425: Prospectus or communication for a business combination

NewcelX Ltd. Form 425: Prospectus or communication for a business combination

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2025-09-04: Form 425; Description FORM 425; Document ea0255971-425_nlspharma.htm.
2025-08-29: Form 425; Description FORM 425; Document ea0255217-425_nlspharma.htm.
2025-07-18: Form 425; Description FORM 425; Document ea0249553-425_nlspharma.htm.
2025-07-01: Form 425; Description FORM 425; Document ea0247659-425_nlspharm.htm.

Filed	Form	Description	Document
2025-09-04	425	FORM 425	ea0255971-425_nlspharma.htm
2025-08-29	425	FORM 425	ea0255217-425_nlspharma.htm
2025-07-18	425	FORM 425	ea0249553-425_nlspharma.htm
2025-07-01	425	FORM 425	ea0247659-425_nlspharm.htm
2025-06-16	425	FORM 425	ea0245735-425_nlspharm.htm
2025-06-06	425	FORM 425	ea024489002-425_nlspharm.htm
2025-04-15	425	FORM 425	ea0237490-425_nlspharma.htm
2025-03-31	425	FORM 425	ea0236265-425_nlspharma.htm
2025-03-10	425	FORM 425	ea0233622-425_nlspharma.htm
2025-02-25	425	FORM 425	ea0231992-425_nlspharma.htm
2025-02-10	425	FORM 425	ea0230492-425_nlspharma.htm
2025-01-31	425	FORM 425	ea0229241-425_nlsphar.htm
2025-01-28	425	FORM 425	ea0228953-425_nlsphar.htm
2025-01-16	425	FORM 425	ea022788602-425_nlspharma.htm
2025-01-08	425	FORM 425	ea0227105-425_nlspharma.htm
2024-12-30	425	FORM 425	ea0226253-425_nlspharma.htm
2024-12-19	425	FORM 425	ea0225128-425_nlspharma.htm
2024-12-11	425	FORM 425	ea0222021-425_nlspharma.htm
2024-11-05	425	FORM 425	ea0220043-425_nlspharma.htm
2024-11-04	425	FORM 425	ea0219780-425_nlspharma.htm